 | Ovid Therapeutics Inc. (NASDAQ:OVID) Given Consensus Rating of "Buy" by Analysts
americanbankingnews.com - April 10 at 6:54 AM |
 | BRIEF-Ovid Therapeutics Announces Closing Of Agreement With Takeda For Global Development And Commercialization Of Soticlestat
msn.com - March 30 at 1:16 PM |
 | Ovid Therapeutics Announces Closing of Agreement with Takeda for Global Development and Commercialization of Soticlestat
finance.yahoo.com - March 30 at 8:16 AM |
| Ovid Therapeutics Inc. (NASDAQ:OVID) Short Interest Update
americanbankingnews.com - March 28 at 4:46 PM |
| News Flash: Analysts Just Made A Notable Upgrade To Their Ovid Therapeutics Inc. (NASDAQ:OVID) Forecasts
finance.yahoo.com - March 20 at 12:45 PM |
 | Ovid Therapeutics Inc. (NASDAQ:OVID) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
nasdaq.com - March 18 at 9:14 AM |
| Ovid Posts Larger-Than-Feared Quarterly Loss, Revenue Beat
finance.yahoo.com - March 16 at 10:38 AM |
| Ovid Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results, Provides Corporate Update for 2021
finance.yahoo.com - March 15 at 8:14 AM |
|
| What Kind Of Investors Own Most Of Ovid Therapeutics Inc. (NASDAQ:OVID)?
finance.yahoo.com - March 10 at 2:59 PM |
 | Ovid Therapeutics Shares Relatively Quiet, See Slightly Volume Uptick As Hearing RBC Downgraded Stock
benzinga.com - March 5 at 4:18 AM |
| KMPH Scores FDA Nod For ADHD Drug, MNOV Quits COVID-19 Vaccine Race, UTHR Gives Up On Trevyent
nasdaq.com - March 4 at 3:16 AM |
| Why Ovid, KemPharm, Sorrento, Aquestive Are Rallying
msn.com - March 3 at 12:15 PM |
| Takeda Secures Global Rights from Ovid Therapeutics to Develop and Commercialize Soticlestat for the Treatment of Children and Adults with Dravet Syndrome and Lennox-Gastaut Syndrome
finance.yahoo.com - March 3 at 7:15 AM |
| Central Nervous System Drugs Global Market Report 2021: COVID 19 Impact and Recovery to 2030
finance.yahoo.com - February 26 at 10:29 AM |
| Is Ovid Therapeutics (NASDAQ:OVID) In A Good Position To Deliver On Growth Plans?
finance.yahoo.com - January 15 at 12:50 PM |
 | Italy’s Angelini to buy Swiss biotech group for $1bn
ft.com - January 3 at 8:07 PM |
 | OVID Jul 2021 10.000 call
uk.finance.yahoo.com - December 26 at 3:00 PM |
| OVID Jul 2021 10.000 put
uk.finance.yahoo.com - December 26 at 12:23 AM |
| OVID Jan 2021 5.000 call
uk.finance.yahoo.com - December 25 at 7:22 PM |
| Is OVID A Good Stock To Buy Right Now?
finance.yahoo.com - December 16 at 9:29 AM |
| Ovid Therapeutics Announces Addition to the Nasdaq Biotechnology Index
finance.yahoo.com - December 16 at 9:29 AM |
 | Ovid Therapeutics Inc Registered Shs Neutral
markets.businessinsider.com - December 3 at 7:37 PM |
| 56 Stocks Moving In Wednesday's Mid-Day Session
msn.com - December 2 at 3:49 PM |
| Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Ovid Therapeutics Inc. (OVID) Investigation
finance.yahoo.com - December 2 at 3:49 PM |
| Why Ovid Therapeutics Stock Is Imploding Today
finance.yahoo.com - December 2 at 3:49 PM |
 | Ovid Therapeutics misses goal in Angelman syndrome treatment
seekingalpha.com - December 1 at 10:14 PM |
| Ovid Therapeutics Announces Phase 3 NEPTUNE Clinical Trial of OV101 for the Treatment of Angelman Syndrome Did Not Meet Primary Endpoint
finance.yahoo.com - December 1 at 5:14 PM |
| Are Options Traders Betting on a Big Move in Ovid Therapeutics (OVID) Stock?
finance.yahoo.com - November 25 at 2:38 PM |
| Dosing underway in Capricor Therapeutics' mid-stage CAP-1002 study in COVID-19
seekingalpha.com - November 24 at 9:22 AM |
| Relief/NeuroRx's RLF-100 results in 72% survival of COVID-19 patients under EAP
seekingalpha.com - November 24 at 4:22 AM |
|
| Ovid Therapeutics to Present at the American Epilepsy Society (AES) 2020 Virtual Congress
markets.businessinsider.com - November 23 at 6:21 PM |
| Ovid Therapeutics to Present at the American Epilepsy Society (AES) 2020 Virtual Congress
finance.yahoo.com - November 23 at 6:21 PM |
| News for Ovid Therapeutics Inc Registered Shs
markets.businessinsider.com - November 23 at 1:20 PM |
| Novavax and Sorrento Therapeutics: Are These Beaten-Down Coronavirus Stocks a Bargain?
nasdaq.com - November 16 at 10:27 AM |
| Ovid Therapeutics Inc. (NASDAQ:OVID) Analysts Just Trimmed Their Revenue Forecasts By 66%
nasdaq.com - November 16 at 10:27 AM |
| These Analysts Think Ovid Therapeutics Inc.'s (NASDAQ:OVID) Sales Are Under Threat
finance.yahoo.com - November 16 at 10:27 AM |
| 15 Heroines review – a triumphant revoicing of Ovid
msn.com - November 15 at 1:09 PM |
| Ovid Therapeutics EPS beats by $0.14, beats on revenue
seekingalpha.com - November 12 at 7:50 PM |
| Ovid Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update
finance.yahoo.com - November 12 at 7:50 PM |
| Encouraging COVID-19 vaccine data fails to lift Arcturus, down 4%
seekingalpha.com - November 9 at 9:21 AM |
| Ovid Therapeutics Inc. (OVID)
finance.yahoo.com - November 7 at 2:26 PM |
| Lipocine: TLANDO Might Become A Potential TRT Option In Patients With COVID-19 Infection
seekingalpha.com - November 6 at 1:23 PM |
| Atea Pharmaceuticals Expands Board of Directors with Appointment of Barbara Duncan
markets.businessinsider.com - November 6 at 8:22 AM |
| Mateon on go with mid-stage study of antisense drug for COVID-19
seekingalpha.com - November 4 at 7:39 AM |
| All Ovid-Elsie students transition to virtual learning due to nearby COVID-19 outbreaks
msn.com - November 2 at 11:21 PM |
| AgeX inks sublicensing pact with ImStem for cell therapy against COVID-19
seekingalpha.com - October 28 at 8:47 AM |
| Nektar Therapeutics on go with study of bempegaldesleukin in COVID-19
seekingalpha.com - October 27 at 8:00 AM |
 | The Drug Industry Gets Behind Fauci
bloomberg.com - October 25 at 12:31 AM |
| Mid-stage study of Appili Therapeutics' favipiravir in COVID-19 underway
seekingalpha.com - October 20 at 8:11 AM |
| Sorrento Therapeutics down following R&D investor update on COVID-19
seekingalpha.com - October 14 at 2:39 PM |
